Biotechnology VALUE FUND II L.P., Insider at ChemoCentryx, Inc. (CCXI), bought 189,800 shares at $5.03 ($951K) on 2013-12-05, disclosed to the SEC on 2013-12-05.
Open-market purchase of $951k CCXI by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.98 | 16,175 | $81K | 8.5% |
| 2 | $4.98 | 49,325 | $246K | 25.8% |
| 3 | $5.03 | 41,451 | $208K | 21.9% |
| 4 | $5.03 | 82,849 | $417K | 43.8% |
| Total | $5.01 avg | 189,800 | $951K | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |